Filed: 5/16/2024ACC: 0001123292-24-000137
📋 What this filing means
ATHYRIUM CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $72.78M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$72.78M
Total AUM (reported)
85.17M
Total Shares
Allocation by class
NOTE 5.250% 2/1$54.10M74.3%
COM NEW$12.02M16.5%
COM$6.66M9.1%
Portfolio Concentration
Top 3$72.78M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 85.17M
Sole
Full voting authority
12.19M
shares
% of voting shares14.3%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
72.98M
shares
% of voting shares85.7%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeNone · 85.7% of voting shares
Institutional Holdings3
Rows:
Omeros Corp
SOLEShares72.98M
TypePRN
Market value$54.10M
74.33%
Sole
0.00
Shared
0.00
None
72.98M
Biora Therapeutics Inc.
SOLEShares10.93M
TypeSH
Market value$12.02M
16.52%
Sole
10.93M
Shared
0.00
None
0.00
PUMA BIOTECHNOLOGY INC
SOLEShares1.26M
TypeSH
Market value$6.66M
9.15%
Sole
1.26M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Omeros CorpSOLE | NOTE 5.250% 2/1 | 72.98M | PRN | $54.10M 74.33% | 0.00 | 0.00 | 72.98M |
Biora Therapeutics Inc.SOLE | COM NEW | 10.93M | SH | $12.02M 16.52% | 10.93M | 0.00 | 0.00 |
PUMA BIOTECHNOLOGY INCSOLE | COM | 1.26M | SH | $6.66M 9.15% | 1.26M | 0.00 | 0.00 |